Hepatocellular adenoma other diagnostic studies

Revision as of 23:07, 9 January 2019 by Zahir Ali Shaikh (talk | contribs)
Jump to navigation Jump to search

Hepatocellular adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatocellular adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatocellular adenoma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatocellular adenoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatocellular adenoma other diagnostic studies

CDC on Hepatocellular adenoma other diagnostic studies

Hepatocellular adenoma other diagnostic studies in the news

Blogs on Hepatocellular adenoma other diagnostic studies

Directions to Hospitals Treating Hepatocellular adenoma

Risk calculators and risk factors for Hepatocellular adenoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]

Overview

The gold standard method for diagnosis of hepatocellular carcinoma is excision biopsy of liver lesions either by surgery or laparoscopically. Percutaneous biopsy is not recommended due to the risk of bleeding and tumor dissemination. Other tests that can be used to differentiate between benign and carcinomatous lesions include; QBend10 and erbB2 immunostaining, comparative genomic insitu hybridization and flourescence insitu hybridization.

Hepatocellular adenoma other diagnostic studies

  • The gold standard test for diagnosis of hepatocellular adenoma is excision biopsy of liver lesions either by surgery or laparoscopically.
  • The microscopic differentiation between benign hepatic adenomas and hepatocellular carcinomas can be difficult, even with tumor tissue.
  • Other diagnostic tests that can be used to differentiate benign and carcinomatous lesions include; QBend10 and erbB2 immunostaining, comparative genomic insitu hybridization and flourescence insitu hybridization.
  • The percutaneous biopsy of hepatic lesions is not recommended due to the risk of bleeding and tumor dissemination.

References


Template:WikiDoc Sources